Skip to main content

Harpoon Therapeutics, Inc.

HARPDelisted Mar 11, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001708493

Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Harpoon Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
−2 vs. Q1 2023
Shares held
16.9M
−544.1K (−3.1%) vs. Q1 2023
Total value
$12.0M
−$959.7K (−7.4%) vs. Q1 2023
New holders
4
10 more added
Sold out
6
11 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HARP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 44 institutions
Q1 2021: 88 institutionsQ2 2021: 85 institutionsQ3 2021: 93 institutionsQ4 2021: 84 institutionsQ1 2022: 79 institutionsQ2 2022: 63 institutionsQ3 2022: 52 institutionsQ4 2022: 49 institutionsQ1 2023: 46 institutionsQ2 2023: 44 institutionsQ3 2023: 32 institutionsQ4 2023: 41 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $12.0M
Q1 2021: $562.3MQ2 2021: $357.3MQ3 2021: $203.9MQ4 2021: $196.3MQ1 2022: $128.2MQ2 2022: $43.4MQ3 2022: $21.0MQ4 2022: $13.7MQ1 2023: $12.9MQ2 2023: $12.0MQ3 2023: $7.53MQ4 2023: $175.5MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding HARP and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202341$175.5M
Q3 202332$7.53M
Q2 202344$12.0M
Q1 202346$12.9M
Q4 202249$13.7M
Q3 202252$21.0M
Q2 202263$43.4M
Q1 202279$128.2M
Q4 202184$196.3M
Q3 202193$203.9M
Q2 202185$357.3M
Q1 202188$562.3M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Harpoon Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding HARP in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
MPM Oncology Impact Management LP3,196,707$2.27M0.46%00.0%Unchanged
New Leaf Venture Partners, L.L.C.3,156,699$2.24M1.92%00.0%Unchanged
MPM Asset Management LLC3,131,388$2.22M1.09%00.0%Unchanged
Franklin Resources Inc1,323,286$939.5K0.00%00.0%Unchanged
Vanguard Group Inc1,153,148$818.7K0.00%00.0%Unchanged
Artal Group S.A.1,000,000$710.0K0.02%00.0%Unchanged
OrbiMed Advisors LLC621,218$441.1K0.01%00.0%Unchanged
Cormorant Asset Management, LP540,600$383.8K0.02%00.0%Unchanged
Kennedy Capital Management, Inc.529,934$376.3K0.01%00.0%Unchanged
Lion Point Capital, LP456,514$324.1K0.24%+287,231+169.7%Added
BlackRock Inc.370,753$263.2K0.00%−56,033−13.1%Reduced
Tekla Capital Management LLC259,910$184.5K0.01%00.0%Unchanged
Geode Capital Management, LLC216,431$153.7K0.00%00.0%Unchanged
Renaissance Technologies LLC213,600$152.0K0.00%+17,180+8.7%Added
Millennium Management LLC166,197$118.0K0.00%−486,626−74.5%Reduced
Bridgeway Capital Management, LLC88,000$62.5K0.00%−12,000−12.0%Reduced
State Street Corp85,232$60.5K0.00%00.0%Unchanged
Acadian Asset Management LLC76,710$53.0K0.00%−36,992−32.5%Reduced
Sequoia Financial Advisors, LLC63,955$45.4K0.00%−36,045−36.0%Reduced
Two Sigma Investments, LP43,144$30.6K0.00%−13,936−24.4%Reduced
Northern Trust Corp37,663$26.7K0.00%−15,284−28.9%Reduced
Barclays PLC33,791$24.0K0.00%+27,029+399.7%Added
Synovus Financial Corp23,000$16.3K0.00%00.0%Unchanged
Jane Street Group, LLC16,734$11.9K0.00%+16,734New
Tower Research Capital LLC (TRC)13,468$9.56K0.00%+3,236+31.6%Added
HRT Financial LP10,894$7.00K0.00%+10,894New
Citadel Advisors LLC6,373$4.53K0.00%+6,373New
Morgan Stanley5,725$4.07K0.00%+2,001+53.7%Added
Group One Trading, L.P.3,848$2.73K0.00%+3,848New
UBS Group AG3,142$2.23K0.00%+600+23.6%Added
Simplex Trading, LLC3,743$2.00K0.00%+2,858+322.9%Added
Federation des caisses Desjardins du Quebec2,000$1.42K0.00%00.0%Unchanged
JPMorgan Chase & Co1,363$9680.00%−73−5.1%Reduced
Federated Hermes, Inc.1,133$8040.00%−1,718−60.3%Reduced
Advisor Group Holdings, Inc.1,070$7590.00%−1,028−49.0%Reduced
Wells Fargo & Company873$6200.00%+26+3.1%Added
Bank of America Corp752$5330.00%−21,697−96.7%Reduced
BNP Paribas Arbitrage, SA428$3040.00%00.0%Unchanged
FMR LLC135$960.00%+105+350.0%Added
US Bancorp89$630.00%00.0%Unchanged
Beaird Harris Wealth Management, LLC75$540.00%00.0%Unchanged
Royal Bank of Canada843$00.00%+243+40.5%Added
Hantz Financial Services, Inc.22$00.00%00.0%Unchanged
IFP Advisors, Inc29––00.0%Unchanged
Bailard, Inc.0$00.00%−63,200−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−53,949−100.0%Sold out
Prudential Financial Inc0$00.00%−43,400−100.0%Sold out
CM Wealth Advisors LLC0$00.00%−50,354−100.0%Sold out
Zacks Investment Management0$00.00%−30,042−100.0%Sold out
Investors Research Corp0$00.00%−60−100.0%Sold out